ArticleAntimicrobial agents and chemotherapy2011

Development of tetravalent, bispecific CCR5 antibodies with antiviral activity against CCR5 monoclonal antibody-resistant HIV-1 strains.

Jürgen Schanzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.